University of PittsburghUniversity of Pittsburgh
Startups
TechnologiesStartupsExpress LicensesCollectionsChat with AI
Sign in
University of Pittsburgh

ECM Therapeutics, Inc.

OverviewRequest InfoMore Like ThisExpress Licenses

Sector

Medical Device

Therapeutic Areas

DermatologyOphthalmology

Therapeutic Indications

Dry eye syndrome

Funding Stage

Series A+

Founders

Stephen BadylakKatie Collins

Website

https://ecmtherapeutics.com/

ECM Therapeutics develops regenerative materials designed to support tissue repair. Based in Warrendale, Pennsylvania, the company brings extracellular matrix hydrogel and matrix-bound nanovesicle technologies from Stephen Badylak’s University of Pittsburgh research into product development. Its cofounders include Badylak and Katie Collins. [1]

The hydrogel platform can be formulated for injection, molding, coating or filling irregular spaces. Its pipeline includes an investigational fistula-repair treatment in Phase 1 and preclinical programs for gastrointestinal stricture and dermal filling. [2]

The company is evaluating ECMT-100 for anorectal fistulas in a first-in-human study. Separately, its ECMT-100 WMD wound-management product received FDA 510(k) clearance in June 2026. [3] [4]

Discover More with AI